Mostrando 342,681 - 342,700 Resultados de 345,093 Para Buscar '"The Trial"', tiempo de consulta: 2.13s Limitar resultados
  1. 342681
    “…BACKGROUND: Narrow spectrum of action through limited molecular targets and unforeseen drug-related toxicities have been the main reasons for drug failures at the phase I clinical trials in complex diseases. Most plant-derived compounds with medicinal values possess poly-pharmacologic properties with overall good tolerability, and, thus, are appropriate in the management of complex diseases, especially cancers. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  2. 342682
  3. 342683
    “…METHODS: This was a systematic review with searches carried out on 13 March 2021 through PubMed, Embase, MEDLINE and CINAHL plus, clinical trials registry and bibliography reviews. Eligibility criteria were: published in English; from 2000 onwards; included adult DM and/or HT patients; examined CoC as their main intervention/exposure; and utilised quantifiable outcome measures (categorised into health indicators and service utilisation). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  4. 342684
    “…This has important implications to identify the eosinophilic and Th2 high endotype both for clinical trials of anti-eosinophil therapies, and to select patients who may respond well to glucocorticosteroids and anti-IL5 therapies.…”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  5. 342685
  6. 342686
    “…We also aimed to compare results from meta-analyses of observational studies against meta-analyses of randomized controlled trials (RCTs) and Mendelian randomization (MR) studies. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  7. 342687
    “…While in randomized clinical trials much effort concentrates on data monitoring, this is rarely the case in observational studies- due to high numbers of cases and often-restricted resources. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  8. 342688
    “…METHODS: PubMed, Web of Science, OVID EMBASE, MEDLINE, The Cochrane database and Clinicaltrials.gov were systematically searched (from inception to 25 January 2021). Trials that randomized adult participants to extended-release formulation of metformin (met-XR), delayed-release (met-DR) or immediate-release metformin (met-IR) were included. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  9. 342689
    “…Currently, there are no systemic agents that have regulatory approval for these disorders, but the mTOR inhibitor sirolimus has been used for several years in clinical trials and off label to address symptoms. There are also other agents under investigation for PIK3CA-related disorders that act as inhibitors to target different components of the PI3K signaling pathway including AKT (miransertib) and PI3K alpha (alpelisib). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  10. 342690
  11. 342691
  12. 342692
    por Ding, Ting, Tang, Dan, Xi, Mingrong
    Publicado 2021
    “…METHODS: We searched EMBASE, MEDLINE, the Cochrane Database of Systematic Reviews and Cochrane Central Register of Controlled Trials, from inception to April 2021. We used appropriate scales to assess the risk of bias. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  13. 342693
    “…METHODS: We searched 13 databases, including PubMed, Medline, Global Health, EMBASE, ADOLEC, Social Policy and Practice, Database of Promoting Health Effectiveness Reviews (DoPHER), Trials Register of Promoting Health Interventions (TRoPHI), EPPI-Centre database of health promotion research (Bibliomap), Web of Science, PsycINFO, Cochrane and Scopus for studies involving arts interventions aimed at reducing any or all components of mental-health-related stigma among youth (10–24-year-olds). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  14. 342694
    por Hober, Candice, Fredeau, Lisa, Pham-Ledard, Anne, Boubaya, Marouane, Herms, Florian, Celerier, Philippe, Aubin, François, Beneton, Nathalie, Dinulescu, Monica, Jannic, Arnaud, Meyer, Nicolas, Duval-Modeste, Anne-Bénédicte, Cesaire, Laure, Neidhardt, Ève-Marie, Archier, Élodie, Dréno, Brigitte, Lesage, Candice, Berthin, Clémence, Kramkimel, Nora, Grange, Florent, de Quatrebarbes, Julie, Stoebner, Pierre-Emmanuel, Poulalhon, Nicolas, Arnault, Jean-Philippe, Abed, Safia, Bonniaud, Bertille, Darras, Sophie, Heidelberger, Valentine, Devaux, Suzanne, Moncourier, Marie, Misery, Laurent, Mansard, Sandrine, Etienne, Maxime, Brunet-Possenti, Florence, Jacobzone, Caroline, Lesbazeilles, Romain, Skowron, François, Sanchez, Julia, Catala, Stéphanie, Samimi, Mahtab, Tazi, Youssef, Spaeth, Dominique, Gaudy-Marqueste, Caroline, Collard, Olivier, Triller, Raoul, Pracht, Marc, Dumas, Marc, Peuvrel, Lucie, Combe, Pierre, Lauche, Olivier, Guillet, Pierre, Reguerre, Yves, Kupfer-Bessaguet, Ingrid, Solub, David, Schoeffler, Amélie, Bedane, Christophe, Quéreux, Gaëlle, Dalac, Sophie, Mortier, Laurent, Maubec, Ève
    Publicado 2021
    “…SIMPLE SUMMARY: Prognosis of advanced cutaneous squamous-cell carcinoma (CSCC) is poor. Recent clinical trials have shown that immunotherapy achieves significantly improved survival of patients with advanced CSCCs. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  15. 342695
  16. 342696
    “…Additional objectives were to further characterize the study sample regarding demographics, clinical parameters and medication usage, with particular reference to blood glucose-lowering agents (GLAs: glucagon-like peptide-1 receptor agonists and sodium-glucose co-transporter-2 inhibitors) with demonstrated cardiovascular benefit in randomized intervention trials. METHODS: Data were collected from adults with T2D managed in primary or specialist care in Australia, China, Japan, Czech Republic, France, Hungary, Italy, Argentina, Brazil, Mexico, Israel, Kingdom of Saudi Arabia, and Turkey in 2019, using standardized methodology. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  17. 342697
  18. 342698
  19. 342699
    “…A Cochrane risk of bias assessment was applied to studies that performed randomized controlled trials and consistency of studies was analysed using I(2) as a test of heterogeneity. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  20. 342700
    “…This tool could be used in clinical practice and clinical trials after validation. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12969-021-00620-3.…”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
Herramientas de búsqueda: RSS